India, July 12 -- Takeda (TAK) and the Government of Indonesia announced a collaboration to strengthen Indonesia's plasma ecosystem. This initiative aims to expand equitable access to lifesaving plasma-derived medicinal products (PDMPs) both within Indonesia and globally. A key milestone in this partnership is the fractionation license granted to Takeda by the Ministry of Health, underscoring Indonesia's commitment to advancing health resilience and biopharmaceutical manufacturing capabilities, the company said in a statement.
The multi-year program, the first of its kind in the ASEAN region, is designed to establish sustainable plasma collection and large-scale manufacturing of PDMPs. With this vision, Indonesia has the potential to becom...